长期服用精神药物的患者初次全膝关节置换术的结果
这项回顾性队列研究纳入514例初次全膝关节置换术患者,排除术前使用阿片类药物的120例后,分析394例中术前服用精神药物的133例(34%)与未服用的261例(66%)。结果显示,服药组术后KSS功能评分、KSS膝关节评分、遗忘关节评分、KOOS-JR、WOMAC及PROMIS评分均显著较低,满意度较低,术后6.4周和12个月阿片类药物使用率显著更高,但并发症和翻修无差异。
要点
- 术前服用精神药物者术后患者报告结局评分和满意度均较低。
- 服药组术后6.4周阿片类药物使用率为52.76%,对照组为13.33%(P<.001)。
- 两组并发症和翻修率无差异。
核心结论
- 术前服用精神药物的患者初次全膝关节置换术后阿片类药物消耗增加、满意度降低、患者报告结局评分较差,应就此进行教育。
- 鉴于接受全膝关节置换术的精神药物服用者数量众多,需要进一步研究以改善该群体的临床结局。
研究设计与样本
- 回顾性队列研究,纳入514例连续接受初次全膝关节置换术的患者。
- 120例(23.3%)因术前使用阿片类药物被排除,剩余394例随访至少1年。
- 394例中133例(34%)术前服用精神药物,与剩余261例(66%)未服用者进行比较。
主要发现
- 服药组术后KSS功能评分、KSS膝关节评分、遗忘关节评分、KOOS-JR、WOMAC及PROMIS评分均显著低于对照组。
- 服药组总体满意度评分(Likert 1至5分)较低,满意或非常满意的患者比例较低(4.55 vs 4.79,P<.001;92.0% vs 97.24%,P=.03)。
- 服药组术后6.4周(范围4至8周)阿片类药物使用率显著更高(52.76% vs 13.33%,P<.001),12个月随访时亦更高(5.51% vs 0.39%,P=.002)。
- 两组并发症和翻修无差异。
临床怎么用
- 作者认为,应向服用精神药物的患者说明初次全膝关节置换术后阿片类药物消耗增加、满意度降低和患者报告结局评分较差的风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psychotropic medications are commonly used to treat several mental health conditions. The aim of this study was to determine the impact of psychotropic medications in patients undergoing primary total knee arthroplasty (TKA) with respect to postoperative opioid use, complications, patient-reported outcome measures, and satisfaction. METHODS: This is a retrospective cohort study of 514 consecutive patients undergoing primary TKA. There were 120 patients (23.3%) who were excluded due to preoperative opioid usage. The remaining 394 patients had a minimum 1-year follow-up. Of those, 133 (34%) were on psychotropic medications preoperatively and were compared to the remaining 261 (66%) patients who were not on psychotropics. Clinical data, satisfaction, Knee Society (KS) scores, Western Ontario McMaster Universities Arthritis Index, Patient-Reported Outcomes Measurement Index Score, Forgotten Joint Scores, Knee Injury and Osteoarthritis Outcome Score for Joint Replacement, postoperative opioid medication usage, and complications were compared. RESULTS: The study cohort (psychotropic medications) had significantly lower postoperative KS Function, KS Knee, Forgotten Joint Scores, Knee Injury and Osteoarthritis Outcome Score for Joint Replacement, Western Ontario McMaster Universities Arthritis Index, and Patient-Reported Outcomes Measurement Index Score compared to the control group. The study group had a lower overall satisfaction score (Likert scale 1 to 5) and a lower percentage of patients either satisfied or very satisfied (4.55 versus 4.79, P < .001; 92.0 versus 97.24%, P = .03, respectively). Postoperative opioid usage was significantly greater in the study group at both 6.4 weeks (range, 4 to 8) and 12-month follow-up (52.76 versus 13.33%, P < .001; 5.51 versus 0.39%, P = .002, respectively). There were no differences in complications and revisions between the groups. CONCLUSIONS: Patients on psychotropic medications should be educated on the risk of increased opioid consumption, diminished satisfaction, and patient-reported outcome measures following primary TKA. Given the large number of patients on psychotropic medications undergoing TKA, additional studies are needed to further improve clinical outcomes in this group.
引用
- Smith NS, Abhari S, Smith LS, et al. Results of Primary Total Knee Arthroplasty in Patients on Chronic Psychotropic Medications. J Arthroplasty. 2024. PMID: 38401620. doi:10.1016/j.arth.2024.02.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。